NK-cell recovery after allogeneic HSCT occurs in the presence of circulating Thymoglobulin (ATG) or Alemtuzumab

Author(s):
Jol-van der Zijde, E.; Jansen-Hoogendijk, A.; Hale, G.; Lankester, A.; Bredius, R.; Tol, M. van
Published
2015
Publication type
Article / Letter to editor
Date issued
2015-03-31
Language
English
Is part of
Bone Marrow Transplantation (2015), Vol. 50, p. S42-S43
hdl
1887/107163